Sipahi I, Tuzcu E M, Moon K-W, Nicholls S J, Schoenhagen P, Zhitnik J, Crowe T D, Kapadia S, Nissen S E
Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio, USA.
Heart. 2008 May;94(5):623-7. doi: 10.1136/hrt.2007.129965. Epub 2007 Dec 10.
Despite the link between positive coronary remodelling and acute ischaemic events, no data exist about the impact of arterial remodelling on subsequent progression of coronary atherosclerosis. The objective of this study was to examine whether extent and direction of arterial remodelling are predictors of progression of coronary atherosclerosis.
DESIGN, SETTING AND PATIENTS: From the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial, 210 focal coronary lesions (single lesion per patient) were identified with <or=50% angiographic diameter stenosis at baseline intravascular ultrasound (IVUS). Remodelling was categorised using the remodelling index.
Lesion sites were matched to the 18-month follow-up IVUS examination and change in atheroma area was calculated. Additionally, change in atheroma volume of the whole imaged artery was calculated.
There were no relationships between baseline remodelling index and change in atheroma area at the lesion site (r = 0.004, p = 0.96) or change in atheroma volume in the whole artery (r = 0.06, p = 0.37). Change in atheroma area was not significantly different in lesions with positive, negative or no remodelling at baseline (0.4 (SD 2.1) vs 0.7 (SD 1.7) vs 0.6 (SD 1.8) mm(2), p = 0.76). Similarly, change in atheroma volume in the whole artery was not significantly different among the three remodelling categories (2.2 (SD 25.0) vs 1.4 (SD 31.2) vs 2.4 (SD 27.1) mm(3), p = 0.98).
Extent and direction of arterial remodelling do not predict subsequent progression of coronary atherosclerosis. Although positively remodelled lesions are associated with unstable clinical presentation, they are not associated with accelerated progression of atherosclerosis during lipid lowering therapy.
尽管冠状动脉正向重塑与急性缺血事件之间存在关联,但关于动脉重塑对冠状动脉粥样硬化后续进展的影响尚无相关数据。本研究的目的是探讨动脉重塑的程度和方向是否为冠状动脉粥样硬化进展的预测指标。
设计、研究地点和患者:从积极降脂逆转动脉粥样硬化(REVERSAL)试验中,识别出210个局灶性冠状动脉病变(每位患者一个病变),这些病变在基线血管内超声(IVUS)检查时血管造影直径狭窄≤50%。使用重塑指数对重塑进行分类。
将病变部位与18个月的随访IVUS检查进行匹配,并计算粥样硬化斑块面积的变化。此外,计算整个成像动脉的粥样硬化斑块体积变化。
基线重塑指数与病变部位粥样硬化斑块面积的变化(r = 0.004,p = 0.96)或整个动脉粥样硬化斑块体积的变化(r = 0.06,p = 0.37)之间均无相关性。基线时正向重塑、负向重塑或无重塑的病变,其粥样硬化斑块面积变化无显著差异(分别为0.4(标准差2.1)、0.7(标准差1.7)和0.6(标准差1.8)mm²,p = 0.76)。同样,在三种重塑类别中,整个动脉的粥样硬化斑块体积变化也无显著差异(分别为2.2(标准差25.0)、1.4(标准差31.2)和2.4(标准差27.1)mm³,p = 0.98)。
动脉重塑的程度和方向不能预测冠状动脉粥样硬化的后续进展。尽管正向重塑的病变与不稳定的临床表现相关,但在降脂治疗期间,它们与动脉粥样硬化的加速进展无关。